Qure.ai has announced Jim Mercadante, a seasoned veteran with 25 years in the medtech industry, as their new chief commercial officer (CCO).
Bringing a wealth of experience in artificial intelligence, medical devices, and the broader medtech sector, Mercadante’s new role aims to strengthen the company’s expanding momentum and success.
“We are thrilled to have Jim Mercadante join us, and we anticipate his leadership will enhance our global sales strategies, fortify our partnerships with healthcare providers and channel partners, and optimize commercial operations for global growth,” stated Prashant Warier, co-founder and CEO of Qure.ai. “Although based in our USA office, he will be actively traveling to drive our global sales initiatives, solidify customer achievements, and streamline commercial processes.”
Based in Mumbai, Qure.ai is renowned for its AI-driven technology designed to rapidly analyze and interpret medical imagery, such as x-rays, CT scans, and ultrasounds, in under a minute. Their FDA-approved and CE-certified AI tools enhance diagnosis efficiency, allowing for more effective patient triage, especially in critical scenarios.
Mercadante’s impressive career portfolio in commercial leadership, sales, and strategic marketing includes prior leadership roles at Abbott, Johnson & Johnson, GE, Terumo, and most recently, Rapid AI. With his guidance, Qure.ai plans to build on their recent Series D funding, aiming for expansion within the U.S. and internationally, supporting ongoing AI acceleration, and pursuing synergistic acquisitions.
“Qure.ai is incredible for its remarkable team, innovative technology, and clear foresight in advancing healthcare,” Mercadante remarked. “I am eager to help drive the company’s growth as we further our global reach and continue to develop AI solutions that tackle significant healthcare obstacles.”